Fund managers falling out of love with CSL but buying these blue-chip instead

Some of our market darlings are starting to lose favour with fund managers as they shift their preference to other parts of the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some of our market darlings are starting to lose favour with fund managers as they shift their preference to other parts of the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index.

The was the findings from JP Morgan's latest monthly Fund Manager Radar report for October, which looks at stocks that institutional investors are buying and selling compared to the previous month.

The broker has created what it calls a "Love Index" to measure where the collective ardour is gathering.

Feeling the love

What fund managers, or fundies, are holding can often sway sentiment towards a stock – particularly at a time like this where the outlook for the market is so uncertain.

"Since the inception of the FMR, we have attempted to assess the balance of local manager positioning by stock in the form of the 'Love Index'," said JP Morgan.

"While the measurement process is blunted by the nature of holding disclosures, the results do provide some insight into stocks that are favoured by managers against those for which there is less clamour."

CSL losing affection

One notable stock that fund managers appear to be cooling towards is the CSL Limited (ASX: CSL) share price. The broker believes this is primarily because of its over-extended valuation.

It's perhaps no coincidence that JP Morgan has just downgraded the blood plasma products maker to "neutral" from "overweight".

The downgrade comes even as CSL provided an upbeat update at the recent Research and Development Briefing. This prompted the broker to increase its earnings per share (EPS) forecast for the company by 3% and 5% for FY20 and FY21, respectively.

But JP Morgan feels all the good news is already in the price with CSL trading around the broker's price target of $270 per share.

3 stocks catching attention

If you are wondering which ASX large caps have become the focus of affection, there are three noteworthy ones.

These are mining giant BHP Group Ltd (ASX: BHP), energy producer Woodside Petroleum Limited (ASX: WPL) and global packing group AMCOR PLC/IDR UNRESTR (ASX: AMC).

BHP had been underheld in March but has progressively been sort after by fundies as it looks like a value buy given its strong balance sheet and cash flow.

"WPL is in focus given our team's recent upgrade alongside the stock moving into the well-held group," said JP Morgan.

"Finally, AMC stands out as a 'quality value' stock where our team has a strong positive bottom-up view."

What's also notable is that materials stocks (meaning mining) have been gaining traction with fundies. Weighting to this sector increased 16 basis points in October to an average overweight of 45 basis points – the highest since November 2018.

BrenLau owns shares of BHP Billiton Limited. Connect with him on Twitter @brenlau.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Amcor Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »